Novo Nordisk's Chief Strategy Officer said, “We are not ruling out; if there is an appropriate target, we will also launch an acquisition in the field of obesity treatment.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.